In DELIVER Phase III Study, Farxiga Achieved Primary Outcome
DELIVER is the world's largest study of heart failure with intact ejection fraction. The DELIVER phase 3 trial produced favourable findings for AstraZeneca. It...
FDA Regulates Use of J&J COVID Jab Due To Risk Of Thrombosis
The US Food and Drug Administration recently announced that the Johnson & Johnson/Janssen COVID-19 vaccine's urgent use permit will be restricted to people 18...
Charles River and Valo Launch Logica, an Integrated AI-Powered Drug Discovery Solution to Rapidly Deliver Optimized Preclinical Assets
Charles River Laboratories International, Inc. and Valo Health, Inc have launched Logica , an artificial intelligence (AI) powered drug solution that directly translates clients’...
AstraZeneca announces plans for new strategic R&D centre and Alexion headquarters in Cambridge, Massachusetts
AstraZeneca announced plans to open a new site at the heart of the Cambridge, MA, life sciences and innovation hub. The new site will...
FDA Expects COVID Vaccines To Become An Annual Occurrence
According to a trio of prominent US Food and Drug Administration experts, the US may need to update its COVID-19 vaccines every year, and...
Camzyos, Possible Mega Cardiac Drug Given Green Light By FDA
Bristol Myers Squibb has gained approval for one of the year's most anticipated medications, following a brief delay in November. Camzyos, a drug developed...
Rinvoq From Abbvie Gets Fourth FDA Approval In Five Months
The pharma version of Fast and Furious has a new superhero. How else to characterise AbbVie's Rinvoq's breakthrough effectiveness? The immunology medicine received its...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...